1 | Allo-hMSCs | - | - | - | - | 2件: 211 211, 299 |
2 | Ambrisentan | 1件: Ambrisentan Ambrisentan | 1件: D07077
D07077
| 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 51 51, 84, 85, 86, 88, 210, 211 |
3 | Autologous (self) mononuclear cells derived from umbilical cord blood | - | - | - | - | 1件: 211 211 |
4 | Autologous cardiac stem cells (JRM-001) | - | - | - | - | 2件: 210 210, 211 |
5 | Autologous cell-based delivery | - | - | - | - | 1件: 211 211 |
6 | Autologous Umbilical Cord Blood | - | - | - | - | 2件: 211 211, 294 |
7 | Bosentan | 1件: Bosentan Bosentan | 2件: D01227
D01227
,
D07538
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
8 | C-kit+ cells | - | - | - | - | 1件: 211 211 |
9 | Cardiac progenitor cell infusion | - | - | - | - | 2件: 210 210, 211 |
10 | Curosurf | 1件: Poractant alfa Poractant alfa | 1件: D08402
D08402
| - | - | 1件: 211 211 |
11 | Erythropoetin | - | - | - | - | 1件: 211 211 |
12 | Lomecel-B medicinal signaling cells | - | - | - | - | 1件: 211 211 |
13 | Longeveron Mesenchymal Stem Cells | - | - | - | - | 1件: 211 211 |
14 | Maternal Hyperoxygenation | - | - | - | - | 1件: 211 211 |
15 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
16 | METHYLPREDNISOLONE SODIUM SUCCINATE | 1件: Methylprednisolone Methylprednisolone | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 6件: 13 13, 46, 49, 50, 51, 211 |
17 | Metyyliprednisoloninatriumsuksinaatti | - | - | - | - | 1件: 211 211 |
18 | MPC | - | - | - | - | 2件: 210 210, 211 |
19 | Nitrogen | 1件: Nitrogen Nitrogen | 1件: D00083
D00083
| - | - | 5件: 5 5, 6, 17, 211, 299 |
20 | Normal Saline | - | - | - | - | 18件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 |
21 | Oxandrolone | 1件: Oxandrolone Oxandrolone | 1件: D00462
D00462
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 2件: 211 211, 285 |
22 | Rexlemestrocel-L | - | - | - | - | 2件: 210 210, 211 |
23 | Sham | - | - | - | - | 1件: 211 211 |
24 | Sildenafil | 1件: Sildenafil Sildenafil | 1件: D08514
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
25 | Solu-Medrol | 1件: Methylprednisolone hemisuccinate Methylprednisolone hemisuccinate | 1件: D05000
D05000
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 13 13, 49, 50, 51, 53, 97, 211 |
26 | Tracleer | 1件: Bosentan Bosentan | 2件: D01227
D01227
,
D07538
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 13 13, 51, 84, 85, 86, 88, 210, 211 |
27 | Vitamin C | 1件: Ascorbic acid Ascorbic acid | 1件: D00018
D00018
| - | - | 6件: 10 10, 192, 206, 210, 211, 212 |